The latest from Mayo Clinic Laboratories
The newsroom features stories of Mayo Clinic Laboratories and its experts in the news. For media inquiries and expert interviews, contact the Media Relations Newsroom at email@example.com, attention: Mayo Clinic Laboratories.
Today's Highlights Include: CDC adds COVID vaccine to routine immunization schedule for kids and adults, Governments target medical debt with COVID relief funds and Minnesota being the 1st state to screen all newborns for serious viral infection.
Today's Highlights Include: USDA proposes new nutrition standards for school meals, virtual care system designed for COVID-19 grows into a multiuse digital health tool, and Mayo Clinic explores use of artificial intelligence. Is It Hype Or Help?
Are you planning to attend Medlab Middle East 2023? If so, make an appointment to stop by Mayo Clinic Laboratories’ booth Z3.A30 to learn more about our comprehensive menu of advanced diagnostic testing.
Topic highlights include: FDA considers major shift in COVID vaccine strategy, DNA from blood samples could help early cancer detection, Wisconsin researchers say, CDC informs staff of reorganization after pandemic criticisms
The New England Journal of Medicine recently published new findings on periprosthetic joint infection by Dr. Robin Patel.
Topic highlights include: Phoenix Children’s opens specialty clinic at Avondale campus, Moderna says RSV vaccine is effective in older adults, WHO questions severity of XBB.1.5 COVID subvariant as U.S. cases rise
Education on this topic decreases misdiagnosis and the possibility of misinterpreting the comments provided by the reporting laboratories.
Topic highlights include: With attention to mpox fading, health officials fear infections will go undetected and unreported, As COVID surges in China, US begins testing more travelers, FDA approves Alzheimer's drug that appears to modestly slow disease
Mayo Clinic Laboratories is excited to announce our participation in Medlab Middle East 2023, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 6–9, 2023.
Mayo Clinic Laboratories, a leading reference laboratory, and Helix, the nation’s leading population genomics and viral surveillance company, today announced a new strategic collaboration that will provide life sciences customers access to a comprehensive joint laboratory offering for research and development initiatives across the drug development lifecycle.
Mayo Clinic Laboratories, a leader in gastroenterology and patient care, will be exhibiting at the Crohn's & Colitis Congress, a premier conference for health care professionals and researchers interested in inflammatory bowel disease (IBD). Mayo Clinic Laboratories offers a comprehensive IBD test menu, including evaluations to diagnose, differentiate, and manage therapies to treat the condition.